Back to search
FDAFDA · Food and drugs·Recall number D-0583-2018

Ibuprofen Tablets USP, 200 mg, 100-count bottles, OTC, Distributed By: Spirit Pharmaceuticals, LLC Ronkonkoma, NY 11779, NDC 68210-0800-1

Published March 14, 2018 · Recall initiated: January 10, 2018

Summary

FDA records drug Class II recall D-0583-2018, published March 14, 2018 and initiated January 10, 2018. Recalling firm: Spirit Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 144 bottles; Lot: Lot#: HJ6138. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations: Ibuprofen is being recalled in response to previous recall

What to do

Voluntary: Firm initiated · Letter

Get an email if VALUMEDS IBUPROFEN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VALUMEDS IBUPROFEN
Manufacturer
Spirit Pharmaceuticals, LLC
Distributor
NY
Lot
Lot#: HJ6138
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ibuprofen Tablets USP, 200 mg, 100-count bottles, OTC, Distributed By: Spirit Pharmaceuticals, LLC Ronkonkoma, NY 11779, NDC 68210-0800-1 recalled?

Yes. FDA published recall D-0583-2018 on March 14, 2018. Reported hazard: CGMP deviations: Ibuprofen is being recalled in response to previous recall

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VALUMEDS IBUPROFEN.